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Otitis media (OM), inflammation of the middle ear, remains the most common cause of hearing impairment in children.
It is also the most common cause of surgery in children in the developed world. There is evidence from studies of the
human population and mouse models that there is a significant genetic component predisposing to OM, yet nothing is
known about the underlying genetic pathways involved in humans. We identified an N-ethyl-N-nitrosourea-induced
dominant mouse mutant Junbo with hearing loss due to chronic suppurative OM and otorrhea. This develops from
acute OM that arises spontaneously in the postnatal period, with the age of onset and early severity dependent on the
microbiological status of the mice and their air quality. We have identified the causal mutation, a missense change in
the C-terminal zinc finger region of the transcription factor Evi1. This protein is expressed in middle ear basal epithelial
cells, fibroblasts, and neutrophil leukocytes at postnatal day 13 and 21 when inflammatory changes are underway. The
identification and characterization of the Junbo mutant elaborates a novel role for Evi1 in mammalian disease and
implicates a new pathway in genetic predisposition to OM.
Citation: Parkinson N, Hardisty-Hughes RE, Tateossian H, Tsai HT, Brooker D, et al. (2006) Mutation at the Evi1 locus in Junbo mice causes susceptibility to otitis media. PLoS
Genet 2(10): e149. DOI: 10.1371/journal.pgen.0020149
Introduction
Otitis media (OM), inﬂammation of the middle ear,
remains the most common cause of hearing impairment in
children [1,2]. Acute episodes of OM in infants and children
are most often associated with middle ear infections involving
the pathogens Streptococcus pneumoniae and Haemophilus inﬂu-
enzae [3]. Prolonged stimulation of the inﬂammatory re-
sponse, along with poor mucociliary clearance, can also lead
to the persistence of middle ear ﬂuid giving rise to the clinical
presentation of otitis media with effusion [2]. In a substantial
portion of children, recurrent episodes of OM or a chronic
suppurative OM will develop. The high prevalence of the
disease, coupled with its recurrent and chronic nature,
accounts for the large number of tympanostomies under-
taken in affected children. OM is still the most common cause
of surgery in children in the developed world. There is still
considerable debate over the etiology of OM and the
underlying pathological mechanisms [2]. However, risk
factors for OM include craniofacial abnormalities, impaired
mucocilliary function, and the presence of an inﬂammatory
stimulus, such as bacteria. There is evidence from studies of
the human population and mouse models that there is a
signiﬁcant genetic component predisposing to recurrent or
chronic OM [4–7], yet little is known about the underlying
genetic pathways involved. While several inbred strains are
predisposed to the development of OM, their genetic analysis
and utility is compounded by the complex genetic bases and
the low penetrance of the phenotype [6]. In addition, there
are several mouse mutants that demonstrate an OM
phenotype, but the OM develops as part of a complex
syndrome with a wide spectrum of phenotypes [6]. It will be
important to identify and characterize the genes underlying
highly penetrant mouse mutants that develop OM in the
absence of other diverse pathology and represent appropri-
ate models for OM in the human population.
Large-scale phenotype-driven mouse ENU (N-ethyl-N-
nitrosourea) mutagenesis programs provide a rich source of
novel mutant phenotypes that are the basis for systematic
efforts to identify the genetic basis for diverse disease states
[8–10]. One such screen at MRC Harwell, recovered a large
number of mutant phenotypes representing ENU-induced
mutations at a number of novel loci in the mammalian
genome [9]. Mouse models have and continue to play an
important role in studying the genetic causes of hearing
impairment. A number of mutations have been cloned and
have provided us with several profound insights into the
critical proteins involved with the development and function
of the auditory apparatus at the level of both the middle and
inner ears [11,12]. Nevertheless, it is clear that we do not
possess mouse mutants for all loci and pathways potentially
involved in hearing impairment.
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identiﬁed in the Harwell mutagenesis program as having a
deafness phenotype. Junbo is a model of OM that shares many
features with the human condition. Acute OM arises
spontaneously in the postnatal period and develops into
chronic suppurative OM with otorrhea. The underlying
molecular basis of this phenotype has been identiﬁed as a
mutation in the Evi1 transcription factor causing a non-
conservative Asn763Ile change in the second of the two zinc-
ﬁnger domains in this protein. The Junbo mouse highlights a
new role for the transcription factor Evi1 and provides the
ﬁrst evidence for the genetic pathways involved in the
etiology of this complex childhood disease.
Results
Identification, Mapping, and Cloning of the Junbo
Mutation
An ENU mutagenesis screen [9] identiﬁed a new dominant
mutant, Junbo (Jbo), with hearing loss. Preliminary phenotyp-
ing using a click-box test (see Materials and Methods) of an
age-matched cohort derived from the founder mouse
indicated that mice demonstrated a hearing loss at ;40 d
after birth (DAB). We used a pooling strategy employing DNA
from affected mice and genome-wide ﬂuorescent simple
sequence length polymorphism-based screening [9,13] to
provide an initial map position for the Jbo mutation on
Chromosome 3. This map position was further reﬁned using
additional affected animals to an approximately 1.5-Mb
region delineated by the Eif5a2 locus and microsatellite
marker D3Mit178. Direct sequence analysis of coding regions
within this interval identiﬁed an A2288T transversion in the
Evi1 locus, causing a nonconservative Asn763Ile change in the
second of the two zinc-ﬁnger domains in this protein (Figure
1A and 1B). No other sequence changes were identiﬁed in any
other coding sequences within the minimal nonrecombinant
region containing the mutation.
A knockout allele of Evi1 has been produced, Evi1
tm1Mmor
[14]. Evi1
tm1Mmor mice carry a targeted deletion resulting in an
isoform-speciﬁc null for the longest Evi1 transcripts, while the
D324 (shorter) isoform [15,16] remains unaltered. This iso-
form lacks the ﬁnal two zinc-ﬁnger motifs from the ﬁrst (N-
terminal) DNA-binding domain and consequently is predicted
to exhibit altered binding abilities. Characterization of
heterozygote mice carrying this targeted mutant failed to
uncover any phenotype, while homozygotes show prenatal
lethality from presumptive cardiac failure [14]. In addition,
these embryos displayed widespread hypocellularity, most
markedly of the cortical mesenchyme, retarded development
of the ﬁrst and second branchial arches, and severely reduced
vasculature of the yolk sac. To conﬁrm that the A2318T
alteration identiﬁed in Evi1 is responsible for the Junbo
phenotype, we undertook a complementation screen between
Jbo/þ and Evi1
tm1Mmor/þ animals. 81 live births were produced
from crosses of Jbo/þ and Evi1
tm1Mmor/þ mice and all were
genotyped. None of the progeny coinherited the Evi1
tm1Mmor
and the Jbo mutations. However, the other expected genotypes
were recovered—Jbo/þ(38%), Evi1
tm1Mmor/þ(28%),þ/þ(33%)—
conﬁrming the allelism of the knockout and Junbo mutant. We
established intercrosses between Jbo/þ animals using in vitro
fertilization and implantation into wild-type females as Jbo/þ
females undergo repeated spontaneous abortion. At 10.5 days
postcoitum (dpc), 17% of homozygote mice had small hind
limbs, a large pericardial sac, and a malformed forebrain,
features demonstrated by the knockout [14]. However, many
homozygotes were scored as normal in appearance at this and
later stages and proceeded to die between E18.5 and birth,
though homozygotes were of comparable body size to wild-
type littermates. It appears that though some homozygote
embryos may die at 10.5 dpc, others continue to develop
unhindered when carried by a wild-type mother. The only
other phenotypic feature detected in Jbo/þ mice was an extra
digit on one forelimb. Jbo/Jbo mice have extra digits on both
forelimbs (see Figure 1C).
Pathology Phenotyping of the Junbo Mutant
To determine the cause of the deafness phenotype in Junbo,
we performed an initial examination of deaf adult animals
and embryonic skeletal preparations (15.5 dpc–18.5 dpc).
This revealed no gross morphological defects of the inner ear
and ossicular chain or ossiﬁcation of the temporal bone and
tympanic ring in Jbo/þ animals. Dissection of the bullae of
seven Jbo/þ mice and four þ/þ mice (.130 DAB) revealed that
the middle ear cavity (MEC) of mutant mice was ﬁlled with
exudate, indicative of OM. X-ray analysis revealed that there
was no consistent abnormality of bullae shape associated with
OM in Jbo/þmice. Examination of seven Jbo/þmice (14 bullae,
.180 DAB) revealed that 6 Jbo/þ mice bullae had a normal
shape and demonstrated radio opacity, indicating the
presence of an effusion in the middle ear, whereas in six
Jbo/þ mice, bullae were misshapen and also had an effusion
present (demonstrated by radio opacity). Although X-ray
imaging is a less sensitive means of diagnosing OM than
histology, two Jbo/þ mice bullae did not demonstrate a radio
opacity reﬂecting the possibility of resolution of a small
number of Junbo mice at advanced age (see below). Control
ears (two wild-type mice, four bullae) were clear of effusion
and presented with a normal bullae shape. We concluded that
the presence of abnormally shaped bullae in the Junbo mutant
is not necessary for the development of an effusion. We
therefore proceeded to study the pathology of the OM in the
postnatal period, at weaning, and in the adult, ﬁrst in
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Synopsis
Otitis media (OM), inflammation of the middle ear, is the most
common cause of deafness in children. Although acute episodes of
OM in children are associated with middle ear infections, in a
substantial portion of cases recurrent episodes of OM, or a chronic
suppurative OM, will develop. There is evidence from genetic
studies of human families that there is a significant genetic
component contributing to the development of recurrent and
chronic forms of OM. However, the genes involved have not been
identified. The authors have identified and characterized mouse
mutants that demonstrate chronic OM as a route to identifying
genes involved with OM. This study describes one mutant, Junbo,
which shares many features with human OM. Junbo develops an
acute OM following birth that subsequently develops into a chronic
suppurative form of OM. Junbo carries a mutation in the tran-
scription factor gene, Evi1. Evi1 is expressed in a variety of cell types
in the middle ear lining when inflammatory changes are underway.
The identification of the Junbo mutation implicates a new gene
involved in predisposition to OM.conventionally housed mice of relatively low microbiological
status and then in speciﬁc pathogen-free (SPF) mice.
In conventionally housed mice we found no evidence of
inﬂammationoftheembryonic connectivetissueorexudation
into the MEC in Jbo/þor wild-type litter mates at 5 DAB. By 13
DAB the MEC is more fully formed and 100% of the Jbo/þmice
and ;33% wild-type mice had acute OM (Figure 2A–2D).
However,Jbo/þmicehadsuppurativeexudateinboththeMECs,
whilewild-typemicehadunilateralOM,orserousexudationin
one ear and suppurative exudation in the contralateral ear.
Typical acute inﬂammatory changes in the MEC mucoperios-
teum included edematous polyps (Figure 2E, which may
represent unresorbed embryonic connective tissue [17]) and/
orbulgingsub-epithelialbullaeﬁlledwithserousﬂuid,stromal
edema, widely patent capillaries, and lymphatics, with variable
numbers of inﬁltrating neutrophil leukocytes. The epithelial
covering was formed by small basal cells or ciliated columnar
cells(Figure2Fand2G).Asecond,mildertypeofOMoccurred
in a further ;27% of wild-type mice consisting of only focal
mucoperiosteal aggregations of neutrophil leucocytes with or
Figure 1. The Evi1 Gene Is Mutated in Junbo Mice
(a) Sequence analysis of the Evi1 locus in BALB/c, C3H/HeN, Jbo/þadult, and Jbo/Jbo embryonic DNA. An A2318T transversion is detected in Jbo/þand
Jbo/Jbo mutants that is not present in either parental substrains.
(b) Schematic of the EVI1 peptide. Ten zinc finger motifs are clustered into two DNA-binding domains, ZF1 and ZF2. EVI1 contains a proline-rich
repressor domain between the two sets of zinc fingers and a highly acidic domain at the C-terminus. Expanded peptide sequence across the ninth zinc
finger motif shows the high degree of conservation of this region between orthologous proteins from different species: Mus musculus (P14404), Rattus
norvegicus (ENSRNOG00000012645), Homo sapien (Q03112), Danio rerio (ENSDARP00000008993), Fugu rubrides (ENSDARP00000008993), Drosophila
melanogaster (CG31753), Caenorhabditis elegans (R53.3a). Contact residues are highlighted in yellow, the position of the Junbo mutation is highlighted
in red.
(c) Extra digits are seen on the forelimbs of both heterozygote and homozygote mice E18.5 (white arrows). In heterozygotes, (Jbo/þ, middle panel) an
extra digit is observed on either forelimb. The homozygotes, (Jbo/Jbo, right panel) have extra digits on both forelimbs. The anterior digit is often
reduced in size in the homozygote limbs (red arrow). Wild-type mice, left panel.
DOI: 10.1371/journal.pgen.0020149.g001
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lished data); ;40% wild-type mice had no evidence of OM at
this age. Importantly, OM appeared at this stage as part of a
more generalized respiratory tract inﬂammation comprising
suppurative rhinitis (Figure 2H) and nasopharyngitis, and
multifocal mild alveolitis/interstitial pneumonia with eosino-
phil leukocytes in perivascular cuffs (Figure 3A and 3B) but
without evidence of intralesional bacteria or viral inclusions.
Therewerenosigniﬁcanthistologicallesionsinintestine,liver,
pancreas, kidney, heart, thymus, and spleen.
AnypostnatalOMhadresolvedinwild-typemicebyweaning
(0% incidence at 21 DAB) and OM was exceptional in adults
(3% incidence). In contrast, OM was present in 100% of Jbo/þ
mice at weaning and occurred in 94% of adult Jbo/þ mice 29
DAB to .180 DAB. Suppurative rhinitis was still present in
some Jbo/þ mice examined, but in two the eosinophilic
pneumonia was absent or minimal. Large numbers of Gram
positivecocciwerepresentinOMexudateatday21in;70%of
cases (Figure 3C), suggesting nasopharyngeal staphylococcal
andstreptococcalﬂoramayplayaroleinprogressionofOM,if
not its initiation in Jbo/þ mice. There was no evidence of
signiﬁcant proliferation of mucous cells or periodic acid-
Schiff-positive mucus in the MEC.
Adult Jbo/þ mice .29 DAB develop bilateral chronic
suppurative OM. Chronic middle ear effusions contained
variable numbers and proportions of viable and necrotic
neutrophil leukocytes and foamy macrophages; bacteria were
infrequently present and there were small numbers of
multinucleate macrophages, cholesterol clefts, and small
amounts of birefringent foreign body (perhaps secondary to
perforation of the eardrum). The effusions did not contain
signiﬁcant amounts of periodic acid-Schiff-positive mucus.
Chronic changes in inﬂamed thickened mucoperiosteum
include formation of multiple polyps (Figure 2I) covered by
low cuboidal cells or hyperplastic ciliated columnar cells and
scattered mucous cells (Figure 2J). The mucoperiosteal
stroma has variable degrees of ﬁbrosis, neutrophil leukocyte
inﬁltration, scattered mast cells, lymphoplasmacytic inﬁl-
Figure 2. Histology of Middle Ear and Nose in Wild-Type and Junbo Mutant Mice
Images (a–h) are from 13-d-old postnatal mice and are given with their original magnification (a) Jbo/þdorsal section of MEC partly filled with exudate
340, (b) þ/þ normal middle ear temporal bone covered with thin mucoperiosteum (arrowheads) 3400, (c) þ/þ inflamed middle ear with thickened
mucoperiosteum with neutrophil leukocyte infiltrates and neutrophil-rich exudates in the MEC3400, (d) Jbo/þmiddle ear with more severe suppurative
exudation into the MEC 3400, (e) Jbo/þ inflamed edematous polyp (arrowhead) of un-resorbed embryonic middle ear connective tissue, tympanic
membrane 3100, (f) Jbo/þ MEC lined by ciliated columnar cells (arrowhead) 3600 (g) Jbo/þ MEC lined by basal cells (arrowhead) 3600, (h) Jbo/þ
suppurative rhinitis: nasal cavity with suppurative exudate, nasal septum with inflamed nasal mucosa 3200.
Images (i–l) are of adult (180-d) Jbo/þmiddle ear with chronic suppurative OM; changes include (i) fibrous polyps (arrowheads)3200, (j) hyperplasia of
ciliated epithelial cells (arrowhead) and fibrosis of mucoperiosteum stroma3400, and (k) fibrous thickening of the tympanic membrane, outer ear canal
3400 compared with (l) normalþ/þtympanic membrane, outer ear canal3400. E, exudate; MP, mucoperiosteum; NC, nasal cavity; NM, nasal mucosa;
NS, nasal septum; OEC, outer ear canal; TB, temporal bone; TM, tympanic membrane
DOI: 10.1371/journal.pgen.0020149.g002
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is patent and can contain exudates, and the epithelial lining
can have elevated numbers of mucous cells and intra-
epithelial leukocytes. Fibrous thickening of the eardrum
(tympanosclerosis) is common (Figure 2K and 2L). OM was
often associated with perforation of the eardrum, possibly
providing drainage to account for apparent resolution of a
few cases: (6%) of OM in the oldest age group of Jbo/þ mice
(.180 DAB).
The Junbo colony has subsequently been re-derived by
embryo transfer into new high-health status facilities (Mary
Lyon Centre, Harwell). Mice are housed in individually
ventilated cages, and screening shows all FELASA-listed
pathogens (see Materials and Methods) have been excluded;
75 cage air changes/h reduce respiratory irritants such as
ammonia to ,3 ppm. In SPF conditions, OM in Jbo/þ mice is
relatively milder at early time points and is not associated
with rhinitis. Typically at 13 DAB there are small numbers of
inﬂammatory cells in the mucoperiosteum and sometimes,
light MEC effusion. By 20–22 DAB and 28 DAB, 4% Jbo/þmice
had bilateral OM, 54% unilateral OM, and 42% had very mild
or no OM. However, by 54 DAB, Jbo/þ mice (100%) had OM,
but in 10% of cases this was unilateral. OM does not occur in
pre-weaned wild-type mice and in only 3% (a single case in a
22-DAB mouse) of older wild-type mice.
Comprehensive pathology phenotyping failed to show a
consistent pattern of signiﬁcant organ pathology outside of
the middle ear in adult Jbo/þ mice. Speciﬁcally there is no
evidence of opportunistic infections in sites such as skin,
lung, urogenital, or gastrointestinal systems that might be a
sign of immune deﬁciency (see below).
In summary, the microbiological status of the mice and/or
air quality affect onset of OM, and under ‘‘dirty’’ conven-
tional conditions even wild-type mice can develop OM in the
postnatal period as part of upper respiratory tract disease;
however, this resolves in wild-type mice by weaning. In
conventionally housed and SPF Jbo/þ mice, OM emerges as a
chronic condition.
Immunology and FACS Analysis of SPF Wild-Type and
Junbo Mice
There were no signiﬁcant differences in the antibody
responses of Jbo/þ and wild-type control mice to immuniza-
tion with T-dependent (IgG1 and IgG2a to keyhole limpet
hemocyanin) and T-independent (IgGM and IgG3 to pneumo-
coccal polysaccharide type 3) antigens (Table S1). FACS
analysis of blood neutrophils identiﬁed by the cell surface
markers Gr-1 and Mac-1 did not reveal signiﬁcant differences
between levels of immature, mature cell forms, and total
circulating blood neutrophils in Jbo/þ and wild-type mice at
either 20–22 DAB or 49–58 DAB. However, there was a
signiﬁcantly lower (p ¼ 0.003) ratio of immature forms in the
circulating neutrophil pool in 20–22 DAB Jbo/þmice, but not
in 54–58 DAB Jbo/þ mice (Table 1).
Expression of Evi1 in Wild-Type and Junbo Mice
We proceeded to investigate the expression of Evi1 in both
embryonic whole-body tissues (E9.5 and at eight intervals
through to birth) and postnatal middle ear tissue (13 DAB, 21
DAB) in order to relate the underlying mutation to the Junbo
phenotype. We examined expression in wild-type and Jbo/þ
mice, but at no time point did we identify any signiﬁcant
differences in expression patterns, up to and including birth,
from those described [14,18]. However, in postnatal head
tissues, we now ﬁnd that Evi1 is expressed in nuclei of
Figure 3. Histology of the Lung and Middle Ear Exudate in Junbo Mice
(a) 13-d postnatal Jbo/þlung with perivascular and peribronchiolar cuffs
containing Sirius red positive eosinophil leukocytes (arrowhead),
bronchiole, pulmonary artery 3400, (b) focal eosiniphilic alveolitis
(arrowhead) and thickened alveolar septae (open arrowhead) with
eosinophil-rich infiltrates. (c) 21-d postnatal Jbo/þMEC pus with colonies
of Gram positive cocci 3600. B, bronchiole; PA, pulmonary artery
DOI: 10.1371/journal.pgen.0020149.g003
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blasts, and basal epithelial cells in the inﬂamed middle ear
lining (Figure 4), and that patterns of expression are similar
in Jbo/þ and wild-type mice.
OM Phenotype of the Evi1
tm1Mmor/þ Mice
OM is not a prominent feature in Evi1
tm1Mmor/þ mice. Only
one of 12 Evi1
tm1Mmor/þ mice .68 DAB had OM, and in this
single case it was unilateral. OM was not present in 15 wild-
type littermates. The absence of OM in Evi1
tm1Mmor/þ mice,
coupled with the presence of extra digits in Jbo/þ and Jbo/Jbo
mice, suggests that the Junbo mutation may have gain-of-
function effects. However, the genetic background of
Evi1
tm1Mmor/þ mice differs from Jbo/þ and Jbo/Jbo mice (see
Materials and Methods). In addition, the Evi1
tm1Mmor mutation
is an isoform- speciﬁc null. It is therefore difﬁcult to reach
deﬁnitive conclusions as to the nature of the Junbo mutation
(see Discussion).
Discussion
A mutation in the Evi1 transcription factor underlies the
development of a chronic suppurative OM in the Junbo
mutant. Genetic mechanisms appear to interact with micro-
biological status and environmental conditions, such that SPF
Jbo/þ mice with improved air quality have milder early OM.
Gnotobiotic studies are planned to investigate the role of
nasopharyngeal Staphylococcus and Streptococcus spp. commen-
sals in OM pathogenesis. The absence of multi-systemic
inﬂammation and opportunistic infections at other sites, and
the normal T-dependent and T-independent immune re-
Table 1. FACS Analysis of the Proportion of Granulocytes in Blood of Wild-Type and Junbo Mice
Genotype Age Granulocytes Mature NL Immature NL Total NL Immature/Total NL Mature/Total NL
Wild-type 20–22 3.99 (0.86–18.32) 0.47 (0.05–3.18) 0.32 (0.02–2.40) 0.78 (0.07–5.58) 0.41 (0.25–0.53) 0.59 (0.47–0.75)
Jbo/þ 20–22 5.05 (0.94–14.02) 0.90 (0.07–3.69) 0.38 (0.02–1.17) 1.28 (0.12–4.48) 0.30 (0.06–0.46) 0.70 (0.54–0.94)
P 0.483 0.483 0.583 0.637 0.003 0.235
Wild-type 49–58 4.89 (2.11–9.76) 1.03 (0.20–2.66) 0.32 (0.09–0.76) 1.35 (0.37–3.42) 0.25 (0.1–0.46) 0.75 (0.54–0.83)
Jbo/þ 49–58 6.61 (2.90–10.30) 1.71 (0.33–4.49) 0.33 (0.07–0.83) 2.04 (0.44–5.32) 0.18 (0.05–0.30) 0.82 (0.70–0.95)
P 0.051 0.066 0.646 0.098 0.085 0.085
Figures in the body of the table are mean proportion of cells (and range) in each class.
For 20–22 DAB n ¼ 20 wild-type, n ¼ 17 Jbo/þ.
For 49–58 DAB n ¼ 14 wild-type, n ¼ 14 Jbo/þ.
The Wilcoxon sum-of-ranks test was used to test for statistical differences.
DOI: 10.1371/journal.pgen.0020149.t001
Figure 4. Evi1 Protein Immunostaining in 13-d-Old Jbo/þ and Wild-Type Mice with Acute OM
(a) Jbo/þpositive myeloid cells in temporal bone marrow3600. Note chondrocytes and osteocytes are also strongly positive. (b) Jbo/þmucoperiosteum
has positive neutrophil leukocytes, fibroblasts, and basal epithelial cell nuclei3600. (c)þ/þsimilar pattern of staining in bone marrow3600 and (d)þ/þ
inflamed mucoperiosteum 3600. B, basal epithelial cell nuclei; C, chrondrocyte; F, fibroblast; MC, myeloid cell; N, neutrophil leukocyte; O, osteocyte
DOI: 10.1371/journal.pgen.0020149.g004
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deﬁciency being responsible for OM.
The Evi1 locus was initially identiﬁed as a common site of
retroviral integration underlying susceptibility to myeloid
tumors in the AKXD mouse recombinant inbred strain
[19,20]. Transcriptional activation of the Evi1 locus by
translocations and inversions leads to myeloid leukemias
and myelodysplastic syndrome in humans [21]. This locus
encodes a 145-kDa nuclear transcription factor with two
distinct zinc-ﬁnger domains composed of seven and three
zinc-ﬁnger motifs, respectively [22]. Each zinc-ﬁnger domain
has been shown to bind speciﬁc target consensus DNA
sequences, and additional proline-rich and highly acidic
domains located within the protein have been demonstrated
to be capable of repressing or activating target promoter
activities, respectively [21–24]. Evi1 has also been shown to be
capable of repressing the TGF-ß signaling pathway through
direct binding of Smad3 mediated by the ﬁrst zinc-ﬁnger
domain, suggesting a functional role in the control of cell
development and proliferation [25]. In addition, cell line
assays have demonstrated a role for Evi1 in the transcrip-
tional control of c-fos and the AP-1 proliferative pathway
through interactions of the second zinc-ﬁnger domain [26].
The Junbo mutation results in a nonconservative Asn763Ile
change in the second of these three zinc-ﬁngers. Previous in
vitro site-directed mutagenesis studies of the contact residues
within these three zinc-ﬁngers uncovered a complete loss of
DNA-binding ability following any residue change [23]. The
Junbo Asn763Ile alteration is within three amino acids of a
contact residue, and the mutated amino acid contributes to
the putative alpha helix of the Cys2His2 structure. While it
seems likely that the Junbo mutation will disturb the function
of the second zinc-ﬁnger domain, it is unclear whether or not
there are effects on the role of the ﬁrst zinc-ﬁnger domain
that is involved in TGF-b signaling.
It is interesting to note that OM is not part of the
phenotype of Evi1
tm1Mmor/þ mice. However, the Evi1
tm1Mmor
allele results in an isoform-speciﬁc allele for the longest Evi1
transcript while the D324 shorter isoform is unaffected. In
addition, the Evi1
tm1Mmor knockout was established in ES-D3
cells with chimaeras subsequently mated to CF-1 mice [14].
Both the presence of the shorter isoform and the dissimilar
genetic backgrounds between Evi1
tm1Mmor/þ mice and Jbo/þ
mice may contribute to the differences in the expressivity of
the OM phenotype. Alternatively, the Junbo mutation may
lead to gain-of-function effects. However, it is not possible at
this stage to distinguish between these possibilities.
A mutation in the Evi1 transcription factor may give rise to
OM by more than one mechanism, given that it is expressed
in a number of different cell types in the middle ear. One
mechanism arises from our observation that Evi1 is expressed
in neutrophil leukocytes during OM development. Evi1 has
multiple functions relating to hematopoietic differentiation
and development of myeloid leukemia [27–30]. One putative
target gene for Evi1 in neutrophil leukocytes is the inositol
triphosphate type 2 receptor gene (Itpr2) that is required for
functional regulation of neutrophil leukocyte maturation via
F-met-leu-phe receptor signaling in response to bacterial
proteins [31]. Our FACS analysis of circulating neutrophils at
two time points, when OM ﬁrst appears and when chronic
suppurative OM is well established, indicates that localized
inﬂammation in the middle ear in Jbo/þ mice does not result
in signiﬁcant neutrophilia. Neutrophils are apparently
released from hematopoietic tissues at comparable levels in
Jbo/þand wild-type mice and there was no detectable block in
neutrophil development in Jbo/þmice. The ratio of immature
neutrophils in the circulating pool was no higher; indeed, it is
reduced in recently weaned mice when ;60% have acute OM.
In older Jbo/þ mice with fully penetrant chronic suppurative
OM, immature and mature neutrophil ratios are not
signiﬁcantly different from wild-type mice.
A variety of in vitro studies have highlighted the role of the
TGFb/SMAD pathway on mucin expression and thus under-
lined the potential importance of this signaling pathway in
OM [32]. A loss of Evi1 function could affect TGFb/SMAD
signaling pathways. There are two in vitro studies that suggest
that Evi1 mutations could affect mucin expression that might
underlie predisoposition to OM. Firstly, nontypeable Haemo-
philus inﬂuenzae (NTHi), a known bacterial pathogen involved
in human OM, activates Tgfb receptor-Smad3/4 signaling that
together with TLR2-MyD88-TAK1-NIK-IKKb/c-IjBa-depend-
ent activation of NF-jB is known to mediate NTHi-induced
MUC2 mucin transcription [33]. Evi1 loss-of-function muta-
tions might lead to a de-repression of the TGFb/SMAD
pathway and an upregulation of MUC2 expression leading to
an enhancement of effusive processes as a contributor to OM.
Alternatively, it has also been shown that NTHi upregulates
MUC5AC mucin production via activation of the TLR2-
MyD88-dependant p38 pathway [34]. However, the activation
of TGFb/SMAD signaling by NTHi also leads to down-
regulation of p38 activity by inducing MAPK phosphatase-1
and suppressing MUC5AC mucin induction. Thus, in this case
loss of Evi1 function and de-repression of the TGFb/SMAD
pathway would presumably lead to increased suppression of
MUC5AC mucin induction that may reduce mucociliary
defense in suppurative OM. Importantly, the identiﬁcation of
the Junbo mutation now provides in vivo evidence to support
the role of these signaling pathways in OM. It will be
interesting to explore further the molecular phenotype of the
Junbo mutant and to examine whether disregulation of mucin
expression is a contributing factor in the development of
OM.
Additional levels of complexity of Evi1 function relevant to
OM pathogenesis may result from the ﬁrst (N-terminal) zinc-
ﬁnger domain binding to a number of putative target genes
Gadd45g, Gata2, Zfpm2/Fog2, Skil (SnoN), Klf5 (BTEB2), Dcn, and
Map3k14 (Nik) [35]. For instance, Evi1 regulation of Nik could
act in the TLR2-MyD88-TAK1-NIK-IKKb/c-IjBa-dependent
activation of NF-jB pathway to mediate NTHi-induced
MUC2 mucin transcription as described above; and also in
the pro inﬂammatory cytokine IL-1 signaling pathway IL-
1R1-MyD88-IRAK-TRAF6-TAK1-NIK-IKK-NF-jB/IjB [36].
In conclusion, the Junbo mutant provides an important
genetic disease model of OM; particularly because it shares
important features with the chronic human condition [7].
Inﬂammatory disease is restricted to the middle ear and is not
a consequence of overt immune deﬁciency. OM arises
spontaneously in the postnatal period, develops into chronic
suppurative OM with otorrhea, with the early severity and age
of onset dependent on microbiological status and/or air
quality. We have shown that a mutation at the Evi1 locus
underlies the susceptibility and persistence of OM. Our
observations underline the role of Evi1 in mucin gene
regulation as a possible contributor to OM. In this regard,
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considered important candidates for examining the genetic
basis for susceptibility to OM in the human population.
Materials and Methods
Mice and deafness screening. The founder mouse carrying the
Junbo mutation was generated in a large-scale ENU mutagenesis
program at Harwell, United Kingdom [9]. Male BALB/c mice were
mutagenized and mated to normal C3H/HeN females, and the
offspring were screened for a variety of defects, including deafness
and vestibular dysfunction. The Jbo founder was identiﬁed because of
a lack of a Preyer reﬂex when presented with a calibrated 20 kHz 90
dB SPL tone burst. For analysis of the phenotype, the colony was
maintained on a C3H/HeN background in accordance with Home
Ofﬁce regulations.
Microbiological status of the mice. Junbo mice were originally
derived in a conventional facility. Sentinel mice from this colony
were seropositive for the FELASA- [37] listed viral agents MHV
(judged by histology to be enteropathic strains), Adenovirus II, and
TMEV, none of which are primary respiratory pathogens [38].
Intestinal ﬂagellates, pinworms, and the opportunist respiratory
pathogen Pasteurella pneumotropica were also common isolates. A
number of pathogens known to cause respiratory disease and/or OM
in the mouse such as pneumonia virus, Sendai virus, Mycoplasma
pulmonis, Streptococcus pneumoniae, and Pseudomonas aeruginosa have not
been found over many years in the sentinel screens. Non-FELASA-
listed bacteria isolated from the nasopharynx of sentinel mice include
Staphylococcus spp., Staphylococcus aureus, Alpha-haemolytic streptococ-
ci, and other Streptococcus spp. Junbo mice are now housed in a high-
health-status SPF unit in which all FELASA-listed pathogens have
been excluded. Non-FELASA nasopharyngeal ﬂora remains the same.
Genetic crosses and mapping. The founder C3HeNBALB/c
ENUF1-
Jbo/þ mouse was maintained by repeated backcrossing to C3H/HeN.
Mutant progeny were identiﬁed by the lack of a Preyer reﬂex. 41
DNAs were initially pooled from affected individuals and a genome
scan was carried out as described [9,13]. A high-resolution genetic
map was constructed using 242 affected progeny N4 and N5
backcross progeny using published microsatellite markers D3Mit90,
D3Mit328, D3Mit92, D3Mit203, D3Mit55, D3Mit178, D3Mit151,
D3Mit273, D3Mit180, D3Mit239, D3Mit21, D3Mit224, D3Mit182,
D3Mit119, D3Mit241, and D3Mit22. The genetic map across the Jbo
locus was constructed by minimizing the number of recombination
events across the region.
The Evi1
tm1Mmor mutation was generated in D3 ES cells with
subsequent matings to CF-1 mice [14]. Evi1
tm1Mmor/þmice were mated
to C3H/HeN mice before crossing to Jbo/þmice for complementation
testing. For phenotypic analysis Evi1
tm1Mmor/þmice were also mated to
C3H/HeN mice and F1 heterozygous mutant progeny along with wild-
type littermate controls aged to appropriate time points.
Pathology, histology, and X-Ray analysis. The onset and time
course of development of the middle ear disease was examined by
histology in conventionally housed postnatal mice 4–5 DAB (ﬁve Jbo/þ,
two þ/þ); postnatal 13 DAB (13 Jbo/þ,1 6þ/þ); at weaning 21 DAB
(seven Jbo/þ,1 7þ/þ); and in adult mice 29 DAB (ﬁve Jbo/þ,1 1þ/þ), 44
DAB (six Jbo/þ, eightþ/þ), 180 DAB (seven Jbo/þ, nineþ/þ), and 180–360
DAB (six Jbo/þ, three þ/þ). Representative mice from one to three
litters were examined at each time point. In a second study to assess
the OM phenotype under SPF conditions, Junbo mice were sampled
from an embryo re-derived colony that was housed in individually
ventilated cages. The cohorts were as follows: 5 DAB (four Jbo/þ, nine
þ/þ), 13 DAB (11 Jbo/þ,1 9þ/þ), 20–22 DAB, 28 DAB (24 Jbo/þ,1 7þ/þ),
49–58 DAB (20 Jbo/þ,1 8þ/þ), and 85–115 DAB (19 Jbo/þ). 12
conventionally housed 68-DAB Evi1
tm1Mmor/þ mice and 15 same-aged
wild-type littermates were also examined for OM.
Tissues were ﬁxed 24–48 h in 10% neutral buffered formalin (NBF)
and embedded in parafﬁn wax. Heads and bones were decalciﬁed 24–
48 h with Immunocal (Decal Corporation, Tallman, New York, United
States). 4-lm dorsal plane sections of decalciﬁed middle ears were
stained with Haemotoxylin and Eosin (H & E). In 13- and 21-DAB
mice with OM, transverse sections of the nasal turbinates, dorsal
plane sections of the oropharynx, lungs, livers, kidneys, heart, spleen,
intestines, pancreas, and livers were examined by histology. Sections
of middle ears, snouts, and lungs from OM cases were examined for
bacteria using Gram stain and Sirius red for eosinophil leukocytes.
To assess the possibility of opportunistic infections at other body
sites, a general pathology screen was performed on four 28-DAB and
seven 56-DAB SPF Jbo/þ mice. In addition, a more extensive whole-
body pathology analysis of 25þ tissues following EMPReSS necropsy
SOPs [39] was performed on four female and three male 180-DAB Jbo/
þ mice; ﬁve female and four male wild-type litter mates were used as
controls.
For X-ray analysis, heads were skinned and the brains and
mandibles removed, and then the skull was ﬁxed in 10% NBF. After
the dorsoventral view was taken, the head was bisected midsagittally
and lateromedial views taken. Images were taken on a MX-20
Faxitron X-ray machine (Faxitron X-ray Corporation, Wheeling,
Illinois, United States) at 26 kV and 0.3 mA with an exposure time of
3s .
Immunohistochemistry. Whole embryos (E9.5, E10.5, E11.5, E12.5,
E13.5, E16.5, and E18.5) and adult heads (13 DAB and 21 DAB) from
wild-type and Jbo/þ mice were used for immunolabelling. 3-lm wax
sections were de-parafﬁnised in xylene substitute and rehydrated
through graded ethanol solutions. Endogenous peroxidase activity
was quenched with 3% hydrogen peroxide in isopropanol. The
sections were microwaved in 10 mM citrate buffer (pH6.0) and rinsed
with phosphate-buffered saline at room temperature. The immunos-
taining was performed using a Dako (Glostrup, Denmark) autostainer
at room temperature. To inhibit the non-speciﬁc endogenous biotin
staining the Dako Biotin Blocking System was used. A blocking
solution of 10% donkey serum (Serotec) was used for 1 h. Goat
polyclonal antibody raised against the carboxy terminus of human
EVI1 was used in concentration 1:100 (Santa Cruz Biotechnology,
Santa Cruz, California, United States) for 1 h. Biotinylated donkey
anti-goat antibody (Santa Cruz Biotechnology) and ChemMate
Detection Kit (Dako) were used to develop the speciﬁc EVI-1 signals.
Negative control sections were incubated in donkey serum and
processed identically. The slides were counterstained with Haema-
toxylin.
Skeletal preparations. Embryos were ﬁxed in 95% ethanol and
processed through a standard alcian blue and alizarin red bone/
cartilage staining procedure.
Immunology and FACS analysis in SPF mice. The T-dependent
arm of the immune system was assessed by immunization with
keyhole limpet hemocycanin and measurement of IgG1 and IgG2a,
and the T-independent arm by immunization with pneumococcal
polysaccharide type 3 and measurement of IgGM and IgG3 in 42–56-
DAB SPF mice (ten Jbo/þ, tenþ/þ) [40]. For FACS analysis whole blood
was collected in lithium heparin tubes from the jugular vein after
overdosing mice with barbiturate-administered IP. SPF mice were
assessed at 20–22 DAB (17 Jbo/þ,2 0þ/þ) and 49–58 DAB (14 Jbo/þ,1 4þ/
þ). FACS analysis of granulocytes was performed after labeling cells
with R-PE-labeled Gr-1 and FITC-labeled Mac-1 markers. The
Wilcoxon sum-of-ranks test was used to test for statistical differences
between Jbo/þ and þ/þ post-bleed antibody titers and granulocyte
parameters.
Supporting Information
Table S1. T-Dependent and T-Independent Responses in Immune-
Challenged Wild-Type and Junbo Mice
Found at DOI: 10.1371/journal.pgen.0020149.st001 (35 KB DOC).
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